Patriot Financial Group Insurance Agency’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20
Closed -$1K 1312
2022
Q2
$1K Hold
20
﹤0.01% 1917
2022
Q1
$2K Hold
20
﹤0.01% 1857
2021
Q4
$2K Hold
20
﹤0.01% 1951
2021
Q3
$2K Hold
20
﹤0.01% 1951
2021
Q2
$2K Hold
20
﹤0.01% 1887
2021
Q1
$2K Hold
20
﹤0.01% 1791
2020
Q4
$2K Hold
20
﹤0.01% 1647
2020
Q3
$2K Hold
20
﹤0.01% 1463
2020
Q2
$2K Hold
20
﹤0.01% 1402
2020
Q1
$1K Hold
20
﹤0.01% 1453
2019
Q4
$2K Hold
20
﹤0.01% 1134
2019
Q3
$2K Hold
20
﹤0.01% 1103
2019
Q2
$2K Buy
+20
New +$2.14K ﹤0.01% 1130

Other funds holding MDGL

Patriot Financial Group Insurance Agency's MDGL Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2022, closing a stake of 20 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in MDGL in Q2 2019 and held it in 13 quarters. The position peaked at $2K in Q1 2022. 135 funds tracked by Wall St. Rank hold MDGL as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Madrigal Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 20 Madrigal Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • Patriot Financial Group Insurance Agency first reported a position in Madrigal Pharmaceuticals in Q2 2019 and held it in 13 quarters.
  • Patriot Financial Group Insurance Agency's Madrigal Pharmaceuticals position peaked at $2K in Q1 2022.
  • 135 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.